David is an Infectious Diseases trained physician who currently serves as the lead physician for the cabotegravir long-acting clinical development program, within ViiV Healthcare. Originally raised in southern California he attended Duke University medical school and completed a combined Masters in Public Health at the University of North Carolina, Chapel Hill. His research focus during his ID fellowship at the University of California, San Diego, was on antifungal immunology and the immunocompromised host. He has spent the last 8 years as medical director of HIV drug development within GSK and ViiV Healthcare, helping to oversee clinical programs from first time in human through registrational studies. He continues to see patients on a weekly basis as an Assistant Consulting professor in Infectious Diseases at Duke University. His three children, 9, 7, and 3 keep him feeling young and old at the same time.